Pratteln, Switzerland

Marcel Meier

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marcel Meier. Retrieved from https://idiyas.com/inventor/marcel-meier-krj4afq3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marcel Meier: Innovator in Pharmaceutical Compositions

Introduction

Marcel Meier is a notable inventor based in Pratteln, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that address gastrointestinal issues.

Latest Patents

Marcel Meier holds a patent for "Pharmaceutical compositions containing lipase inhibitor." This invention provides orally administrable pharmaceutical compositions that include an inhibitor of gastrointestinal lipase, along with additives such as non-digestible, non-fermentable, hydrophilic, and hydrocolloidal food-grade thickeners and emulsifiers. The patent outlines methods for preventing and treating anal leakage of oil in patients by administering these compositions.

Career Highlights

Marcel Meier is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work focuses on innovative solutions that enhance patient care and improve health outcomes.

Collaborations

He has collaborated with notable colleagues, including Manuela Hug and Hans-Peter Märki, contributing to advancements in pharmaceutical research and development.

Conclusion

Marcel Meier's innovative work in pharmaceutical compositions demonstrates his commitment to improving healthcare solutions. His contributions are vital in addressing specific medical challenges faced by patients today.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…